Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study
Aim: Non-alcoholic steatohepatitis (NASH), ormetabolic dysfunction-associated steatohepatitis (MASH), is a severe form of non-alcoholic fatty liver disease (NAFLD) ormetabolic dysfunction-associated liver disease (MASLD), that may progress to advanced liver disease. Costs associated with progression...
Saved in:
Main Authors: | Yestle Kim (Author), Joseph Medicis (Author), Matthew Davis (Author), Dominic Nunag (Author), Robert Gish (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis
by: Kota Saito, et al.
Published: (2024) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023) -
Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024) -
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
by: Mehmet Yalniz, et al.
Published: (2006) -
Bardet-Biedl syndrome with nonalcoholic steatohepatitis, hypertension, and hypothyroidism
by: Yatendra Singh, et al.
Published: (2016)